ArticleScientific reports2023

Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.

Carlos A Huertas-Caro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.